Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 700 participants.

Also called NCT07445737

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 700 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07445737
  • EU CT 2025-523349-86-00
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07445737. Randomized; no masking; primary purpose treatment. Start 2026-06 (anticipated); primary completion 2029-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction
Acronym
MAMI
Condition
STEMI - ST Elevation Myocardial Infarction
Intervention (Drug)
Methoxyflurane
Intervention (Drug)
Morphine
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)
Collaborator
Medical Developments International Limited (class: industry)

Record details

Record id
cardio:ct-nct07445737
Content hash
1b302a76f8396fad7e97c98bf40ba4961e03624303c5fa084aad31522fffba63